AMEX:CRHM

Stock Analysis Report

CRH Medical Corporation

Executive Summary

CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada.

Snowflake

Share Price & News

How has CRH Medical Corporation's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-0.7%

CRHM

0%

0%

Market


1 Year Return

-27.1%

CRHM

0%

0%

Market

CRHM underperformed the Healthcare industry which returned -9.1% over the past year.

CRHM underperformed the Market in United States of America which returned 0.7% over the past year.


Share holder returns

CRHMIndustryMarket
7 Day-0.7%0%0%
30 Day-3.2%0%0%
90 Day3.5%0%0%
1 Year-27.1%-27.1%0%0%0%0%
3 Year-23.5%-23.5%0%0%0%0%
5 Year379.2%379.2%0%0%0%0%

Price Volatility Vs. Market

How volatile is CRH Medical Corporation's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is CRH Medical Corporation undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

CRH Medical's share price is below the future cash flow value, and at a moderate discount (> 20%).

CRH Medical's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

CRH Medical is overvalued based on earnings compared to the US Healthcare industry average.

CRH Medical is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

CRH Medical is good value based on expected growth next year.


Price Based on Value of Assets

CRH Medical is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is CRH Medical Corporation expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

78.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

CRH Medical's revenue is expected to grow by 7.9% yearly, however this is not considered high growth (20% yearly).

CRH Medical's earnings are expected to grow significantly at over 20% yearly.

CRH Medical's revenue growth is expected to exceed the United States of America market average.

CRH Medical's earnings growth is expected to exceed the United States of America market average.

CRH Medical's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if CRH Medical will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has CRH Medical Corporation performed over the past 5 years?

22.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

CRH Medical has delivered over 20% year on year earnings growth in the past 5 years.

CRH Medical's 1-year earnings growth is negative, it can't be compared to the 5-year average.

CRH Medical's 1-year earnings growth is negative, it can't be compared to the US Healthcare industry average.


Return on Equity

CRH Medical has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

CRH Medical used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

CRH Medical's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is CRH Medical Corporation's financial position?


Financial Position Analysis

CRH Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

CRH Medical's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

CRH Medical's level of debt (51.7%) compared to net worth is high (greater than 40%).

Unable to establish if CRH Medical's debt level has increased without past 5-year debt data.

Debt is well covered by operating cash flow (67.4%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 5.4x coverage).


Balance Sheet

Low level of unsold assets.

Debt is not covered by short term assets, assets are 0.4x debt.


Next Steps

Dividend

What is current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate CRH Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate CRH Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as CRH Medical has not reported any payouts.

Unable to verify if CRH Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as CRH Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of salary, the management and board of directors tenure and is there insider trading?

3.2yrs

Average management tenure


CEO

Tushar Ramani (55yo)

0.4yrs

Tenure

0

Dr. Tushar Ramani, MD has been Chief Executive Officer and Director of CRH Medical Corporation since April 9, 2019. He is a 30 year veteran of the anesthesia industry. He has been President of TeamHealth A ...


Management Age and Tenure

3.2yrs

Average Tenure

55yo

Average Age

The tenure for the CRH Medical management team is about average.


Board Age and Tenure

13.3yrs

Average Tenure

64yo

Average Age

The average tenure for the CRH Medical board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$102,53113 Dec 18
Ian Webb
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares29,620
Max PriceUS$3.46

Ownership Breakdown


Management Team

  • Richard Bear (56yo)

    CFO & Corporate Secretary

    • Tenure: 13.5yrs
    • Compensation: US$490.00k
  • Tushar Ramani (55yo)

    CEO & Director

    • Tenure: 0.4yrs
  • Jay Kreger (50yo)

    President of CRH Anesthesia Management

    • Tenure: 3.2yrs
    • Compensation: US$353.53k

Board Members

  • Tony Holler (67yo)

    Independent Chairman

    • Tenure: 13.8yrs
    • Compensation: US$152.49k
  • Todd Patrick (56yo)

    Independent Director

    • Tenure: 13.3yrs
    • Compensation: US$142.49k
  • Ian Webb (68yo)

    Independent Director

    • Tenure: 13.3yrs
    • Compensation: US$142.49k
  • Steven Wexner

    Member of Advisory Board

    • Tenure: 0yrs
  • Marvin Corman

    Member of Advisory Board

    • Tenure: 0yrs
  • Ian Cleator

    Member of The Advisory Board

    • Tenure: 0yrs
    • Compensation: US$20.08k
  • Tushar Ramani (55yo)

    CEO & Director

    • Tenure: 0.4yrs
  • Dave Johnson (64yo)

    Independent Director

    • Tenure: 9.3yrs
    • Compensation: US$121.49k

Company Information

CRH Medical Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CRH Medical Corporation
  • Ticker: CRHM
  • Exchange: AMEX
  • Founded: 2000
  • Industry:
  • Sector: Healthcare
  • Market Cap: CA$284.627m
  • Listing Market Cap: CA$214.617m
  • Shares outstanding: 71.88m
  • Website: https://investors.crhsystem.com

Number of Employees


Location

  • CRH Medical Corporation

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRHTSX (The Toronto Stock Exchange)YesCommon SharesCACADJul 2003
CRHMAMEX (NYSE MKT LLC)YesCommon SharesUSUSDJul 2003

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/23 00:19
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.